Nobody told me that running two companies would be less like juggling and more like speaking two languages simultaneously.

I built Techton Life Spaces first. Real estate is a world of physical certainty where you have a land you can walk on, concrete you can touch, a date on a possession letter you can hold someone to. Then I started TerraPHA, a biotech company working with PHA biopolymers in agriculture, aquaculture, and animal nutrition. And the moment I had a foot in both worlds, I began to notice how much each industry had been quietly hiding from me; not out of dishonesty, but because you only see the gaps in one framework when you are standing inside a different one.

These are the lessons that have genuinely changed how I build, decide, and lead.

Lesson One: Feedback Is Everything

The most disorienting thing about moving between real estate and biotech was the difference in how quickly reality talks back to you.

In real estate, a bad design decision can hide for 18 to 36 months through construction, possession, and the first year of occupancy before the complaint registers clearly enough to matter. In biotech, a flawed formulation or a poorly calibrated fermentation parameter shows up in days. The petri dish does not wait for your quarterly review.

This forced me to build two completely different internal cadences. In biotech, I learned to hold decisions, to treat every hypothesis as provisional until the data says otherwise. In real estate, where changing course midstream is enormously expensive, I learned to be more deliberate upfront, because the feedback loop is slow and forgiveness is rare. Neither approach is universally correct. But carrying both has made me better at reading which mode a situation demands.

Lesson Two: People Are the Only Variable That Never Changes

I expected the industries to require different kinds of people. They do, technically. A fermentation scientist and a site engineer do not swap roles easily. But the qualities that determine whether someone makes a team genuinely excellent are identical in both worlds. Intellectual honesty, the willingness to say “I don’t know” before it becomes a crisis, and the ability to care about the outcome more than about being right.

I have been wrong about people in both directions, held on to the wrong person too long because the relationship was comfortable, and let the right person walk because I was too slow to see what they were building. The regrets are the same in both industries, and they sting with exactly the same weight.

Real estate demands patience and people intuition in a particular way. You are managing stakeholders, buyers, contractors, and civic relationships across years. Biotech demands systems thinking and capital discipline with an intensity that keeps you honest daily. But communication which is the ability to translate between the logic of your conviction and the reality of your audience is non-negotiable in both, and equally punishing when you get it wrong.

Lesson Three: Capital Must Be Respected

In real estate, money follows a legible asset revolving around land, construction stages, RERA milestones. The story is physical and sequential. Capital is comfortable.

Biotech capital is a bet on the process, on the reproducibility of biology at scale, on regulatory pathways that shift, on intellectual property that is more valuable than any piece of land but infinitely harder to collateralise. 

Learning to present risk honestly, in the grammar that a particular type of capital understands, is one of the less glamorous but most important things I have done. It is different in every room you walk into. And it is never finished.

Lesson Four: Systems Outlast Decisions

The single best thing I have done in both companies is invest in building systems before building scale.

In Techton, this meant creating a documentation and quality review process that existed before we needed it before the handover disputes, the contractor disagreements, the RERA queries. In TerraPHA, it meant building the fermentation protocols, quality benchmarks, and supplier standards into the DNA of the company while we were still small enough to do it thoughtfully.

Both decisions cost time and money at a stage when time and money felt scarce. Both have paid back many times over. A good system absorbs pressure without drama. A bad one or no system at all means that every growth stage requires you to solve the same problems again from scratch, just at higher stakes.

The Lesson Underneath All the Lessons

If I had to name the one thing that has changed most profoundly in how I think about leadership since running two very different companies simultaneously, it is this that certainty is a posture, not a state.

The most confident-seeming founders I have met are not the ones who know the most. They are the ones who have made peace with not knowing and who have built enough internal infrastructure, enough good people around them, and enough systems beneath them that uncertainty stops being a threat and starts being simply the condition of the work.

Real estate taught me that. Biotech confirmed it. Every day since, I have been trying to get more comfortable with the unresolved.

I do not always succeed. But I have learned to stop pretending otherwise.